Cargando…
Podoplanin promotes progression of malignant pleural mesothelioma by regulating motility and focus formation
Malignant pleural mesothelioma (MPM) is characterized by dissemination and aggressive growth in the thoracic cavity. Podoplanin (PDPN) is an established diagnostic marker for MPM, but the function of PDPN in MPM is not fully understood. The purpose of this study was to determine the pathogenetic fun...
Autores principales: | Takeuchi, Shinji, Fukuda, Koji, Yamada, Tadaaki, Arai, Sachiko, Takagi, Satoshi, Ishii, Genichiro, Ochiai, Atsushi, Iwakiri, Shotaro, Itoi, Kazumi, Uehara, Hisanori, Nishihara, Hiroshi, Fujita, Naoya, Yano, Seiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406599/ https://www.ncbi.nlm.nih.gov/pubmed/28182302 http://dx.doi.org/10.1111/cas.13190 |
Ejemplares similares
-
Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma
por: Li, Qi, et al.
Publicado: (2015) -
Targeted Phototherapy for Malignant Pleural Mesothelioma: Near-Infrared Photoimmunotherapy Targeting Podoplanin
por: Nishinaga, Yuko, et al.
Publicado: (2020) -
Antitumor effect of novel anti‐podoplanin antibody NZ‐12 against malignant pleural mesothelioma in an orthotopic xenograft model
por: Abe, Shinji, et al.
Publicado: (2016) -
In vivo imaging models of bone and brain metastases and pleural carcinomatosis with a novel human EML4-ALK lung cancer cell line
por: Nanjo, Shigeki, et al.
Publicado: (2015) -
Novel circulating tumor cell-detection chip combining conventional podoplanin and EGFR antibodies for all histological malignant pleural mesothelioma
por: Kanayama, Masatoshi, et al.
Publicado: (2021)